+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • September 2024
  • Region: Global
  • IMARC Group
  • ID: 5911793
Description Jump to:
The global canine atopic dermatitis market size reached US$ 2.1 Billion in 2023. Looking forward, the market is expected to reach US$ 7.0 Billion by 2032, exhibiting a growth rate (CAGR) of 14.3% during 2023-2032.

Canine atopic dermatitis (CAD) is an allergic skin disease in dogs caused by allergens, such as pollens, house dust, insect bites, grass and food ingredients. It is an inherited predisposition that generally affects dogs aged between six months to three years. It commonly affects the ventral abdomen, mouth, eyes, interdigital skin, ear pinnae, carpal, elbow and perineal area of the animals.

CAD is characterized by various symptoms, such as excessive scratching, inflammation and itching around paws, underarms and face. It can be treated by immuno-suppressants, monoclonal anatomy and glucocorticoids. They can be administered through oral, injectables and topical medications. It is known to be highly prevalent in German shepherds, Labradors, golden retrievers and pugs.

Canine Atopic Dermatitis Market Trends:

The increasing occurrence of CAD in domesticated dogs across the globe is one of the key factors creating a positive outlook for the market. This can be attributed to the changing environmental conditions, rising air pollution levels and prolonged exposure to allergens. Moreover, the increasing concerns and rising awareness among pet owners regarding early symptoms and signs of CAD, such as redness, greasy skin and yeasty smell, are providing a thrust to the market growth. Additionally, the widespread adoption of monoclonal antibodies for the treatment of the disease is favoring the market growth. These antibodies aid in directing the required immune response and calming the spread of the disease.

In line with this, the increasing number of veterinary practitioners, hospitals and clinics dedicated to providing improved care for animals is positively impacting the market growth. Other factors, including the implementation of various government initiatives to restrict the usage of off-label human drugs on animals, along with extensive research and development (R&D) in the field of veterinary sciences, are anticipated to drive the market toward growth.

Key Market Segmentation:

This report provides an analysis of the key trends in each sub-segment of the global canine atopic dermatitis market report, along with forecasts at the global, regional and country level from 2024-2032. The report has categorized the market based on drug class type, route of administration and distribution channel.

Breakup by Drug Class Type:

  • Glucocorticoids
  • Immunosuppressants
  • Monoclonal Antibody
  • Others

Breakup by Route of Administration:

  • Topical
  • Oral
  • Injectable

Breakup by Distribution Channel:

  • Veterinary Hospitals
  • Pet Clinics
  • Pharmacies and Drugstores
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Bimeda Inc., Bioceltix SA, Boehringer Ingelheim International GmbH, Ceva Santé Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Toray Industries Inc., Vetoquinol S.A., Virbac and Zoetis Inc.

Key Questions Answered in This Report:

  • How has the global canine atopic dermatitis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global canine atopic dermatitis market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global canine atopic dermatitis market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Canine Atopic Dermatitis Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class Type
6.1 Glucocorticoids
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Immunosuppressants
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Monoclonal Antibody
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Topical
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Injectable
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Veterinary Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pet Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Pharmacies and Drugstores
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AB Science
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.2 Bimeda Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bioceltix SA
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Boehringer Ingelheim International GmbH
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Ceva Santé Animale
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Dechra Pharmaceuticals PLC
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Elanco Animal Health Incorporated
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Phibro Animal Health Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Toray Industries Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Vetoquinol S.A.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.11 Virbac
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Zoetis Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Canine Atopic Dermatitis Market: Major Drivers and Challenges
Figure 2: Global: Canine Atopic Dermatitis Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Canine Atopic Dermatitis Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Canine Atopic Dermatitis Market: Breakup by Drug Class Type (in %), 2023
Figure 5: Global: Canine Atopic Dermatitis Market: Breakup by Route of Administration (in %), 2023
Figure 6: Global: Canine Atopic Dermatitis Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Canine Atopic Dermatitis Market: Breakup by Region (in %), 2023
Figure 8: Global: Canine Atopic Dermatitis (Glucocorticoids) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Canine Atopic Dermatitis (Glucocorticoids) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Canine Atopic Dermatitis (Immunosuppressants) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Canine Atopic Dermatitis (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Canine Atopic Dermatitis (Topical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Canine Atopic Dermatitis (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Canine Atopic Dermatitis (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Canine Atopic Dermatitis (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Canine Atopic Dermatitis (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Canine Atopic Dermatitis (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Canine Atopic Dermatitis (Pet Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Canine Atopic Dermatitis (Pet Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: North America: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: North America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: United States: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: United States: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Canada: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Canada: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Asia-Pacific: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Asia-Pacific: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: China: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: China: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Japan: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Japan: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: India: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: India: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: South Korea: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: South Korea: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Australia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Australia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Indonesia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Indonesia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Europe: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Europe: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Germany: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Germany: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: France: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: France: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: United Kingdom: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: United Kingdom: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Italy: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Italy: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Spain: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Spain: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Russia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Russia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Latin America: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Latin America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Brazil: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Brazil: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Mexico: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Mexico: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Middle East and Africa: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Middle East and Africa: Canine Atopic Dermatitis Market: Breakup by Country (in %), 2023
Figure 78: Middle East and Africa: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Global: Canine Atopic Dermatitis Industry: SWOT Analysis
Figure 80: Global: Canine Atopic Dermatitis Industry: Value Chain Analysis
Figure 81: Global: Canine Atopic Dermatitis Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Canine Atopic Dermatitis Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Drug Class Type (in Million US$), 2024-2032
Table 3: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 4: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Canine Atopic Dermatitis Market: Competitive Structure
Table 7: Global: Canine Atopic Dermatitis Market: Key Players

Companies Mentioned

  • AB Science
  • Bimeda Inc.
  • Bioceltix SA
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Phibro Animal Health Corporation
  • Toray Industries Inc.
  • Vetoquinol S.A.
  • Virbac
  • Zoetis Inc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages140
PublishedSeptember 2024
Forecast Period2023 - 2032
Estimated Market Value ( USD ) in 2023 $ 2.1 Billion
Forecasted Market Value ( USD ) by 2032 $ 7 Billion
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Canine Atopic Dermatitis Market by Product, Allergen, Route of Administration, Distribution Channel, End-User - Global Forecast 2025-2030 - Product Image

Canine Atopic Dermatitis Market by Product, Allergen, Route of Administration, Distribution Channel, End-User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Canine Atopic Dermatitis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Canine Atopic Dermatitis Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 79 Pages
  • Global
From
Canine Atopic Dermatitis - Global Strategic Business Report - Product Image

Canine Atopic Dermatitis - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
Canine Atopic Dermatitis Treatment Market - Product Image

Canine Atopic Dermatitis Treatment Market

  • Report
  • 200 Pages
  • Global
From
Canine Atopic Dermatitis Market 2024-2028 - Product Image

Canine Atopic Dermatitis Market 2024-2028

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.